The Market Reports

Index

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Stimulant

1.2.3 Non-stimulant

1.3 Market by Application

1.3.1 Global Attention Deficit and Hyperactivity Disorder Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Attention Deficit and Hyperactivity Disorder Market Perspective (2019-2030)

2.2 Attention Deficit and Hyperactivity Disorder Growth Trends by Region

2.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2019-2024)

2.2.3 Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2025-2030)

2.3 Attention Deficit and Hyperactivity Disorder Market Dynamics

2.3.1 Attention Deficit and Hyperactivity Disorder Industry Trends

2.3.2 Attention Deficit and Hyperactivity Disorder Market Drivers

2.3.3 Attention Deficit and Hyperactivity Disorder Market Challenges

2.3.4 Attention Deficit and Hyperactivity Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue

3.1.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue (2019-2024)

3.1.2 Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2019-2024)

3.2 Global Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Attention Deficit and Hyperactivity Disorder Revenue

3.4 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio

3.4.1 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit and Hyperactivity Disorder Revenue in 2023

3.5 Attention Deficit and Hyperactivity Disorder Key Players Head office and Area Served

3.6 Key Players Attention Deficit and Hyperactivity Disorder Product Solution and Service

3.7 Date of Enter into Attention Deficit and Hyperactivity Disorder Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Attention Deficit and Hyperactivity Disorder Breakdown Data by Type

4.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2019-2024)

4.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2025-2030)

5 Attention Deficit and Hyperactivity Disorder Breakdown Data by Application

5.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2019-2024)

5.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Attention Deficit and Hyperactivity Disorder Market Size (2019-2030)

6.2 North America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024)

6.4 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Attention Deficit and Hyperactivity Disorder Market Size (2019-2030)

7.2 Europe Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024)

7.4 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size (2019-2030)

8.2 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2019-2024)

8.4 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Attention Deficit and Hyperactivity Disorder Market Size (2019-2030)

9.2 Latin America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024)

9.4 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size (2019-2030)

10.2 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024)

10.4 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Detail

11.1.2 Takeda Business Overview

11.1.3 Takeda Attention Deficit and Hyperactivity Disorder Introduction

11.1.4 Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.1.5 Takeda Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Attention Deficit and Hyperactivity Disorder Introduction

11.2.4 Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Attention Deficit and Hyperactivity Disorder Introduction

11.3.4 Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Detail

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Attention Deficit and Hyperactivity Disorder Introduction

11.4.4 Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.4.5 Eli Lilly Recent Development

11.5 Tris Pharma

11.5.1 Tris Pharma Company Detail

11.5.2 Tris Pharma Business Overview

11.5.3 Tris Pharma Attention Deficit and Hyperactivity Disorder Introduction

11.5.4 Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.5.5 Tris Pharma Recent Development

11.6 Neos Therapeutics

11.6.1 Neos Therapeutics Company Detail

11.6.2 Neos Therapeutics Business Overview

11.6.3 Neos Therapeutics Attention Deficit and Hyperactivity Disorder Introduction

11.6.4 Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.6.5 Neos Therapeutics Recent Development

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Detail

11.7.2 Mallinckrodt Business Overview

11.7.3 Mallinckrodt Attention Deficit and Hyperactivity Disorder Introduction

11.7.4 Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.7.5 Mallinckrodt Recent Development

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Detail

11.8.2 Amneal Pharmaceuticals Business Overview

11.8.3 Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction

11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.8.5 Amneal Pharmaceuticals Recent Development

11.9 Noven Pharmaceuticals

11.9.1 Noven Pharmaceuticals Company Detail

11.9.2 Noven Pharmaceuticals Business Overview

11.9.3 Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction

11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.9.5 Noven Pharmaceuticals Recent Development

11.10 Purdue Parma

11.10.1 Purdue Parma Company Detail

11.10.2 Purdue Parma Business Overview

11.10.3 Purdue Parma Attention Deficit and Hyperactivity Disorder Introduction

11.10.4 Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

11.10.5 Purdue Parma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

List of Tables

Table 1. Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Stimulant

Table 3. Key Players of Non-stimulant

Table 4. Global Attention Deficit and Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2019-2024)

Table 8. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2025-2030)

Table 10. Attention Deficit and Hyperactivity Disorder Market Trends

Table 11. Attention Deficit and Hyperactivity Disorder Market Drivers

Table 12. Attention Deficit and Hyperactivity Disorder Market Challenges

Table 13. Attention Deficit and Hyperactivity Disorder Market Restraints

Table 14. Global Attention Deficit and Hyperactivity Disorder Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Attention Deficit and Hyperactivity Disorder Market Share by Players (2019-2024)

Table 16. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2023)

Table 17. Ranking of Global Top Attention Deficit and Hyperactivity Disorder Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Attention Deficit and Hyperactivity Disorder Product Solution and Service

Table 21. Date of Enter into Attention Deficit and Hyperactivity Disorder Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Attention Deficit and Hyperactivity Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2019-2024)

Table 25. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2025-2030)

Table 27. Global Attention Deficit and Hyperactivity Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2019-2024)

Table 29. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2025-2030)

Table 31. North America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 46. Takeda Company Detail

Table 47. Takeda Business Overview

Table 48. Takeda Attention Deficit and Hyperactivity Disorder Product

Table 49. Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 50. Takeda Recent Development

Table 51. Johnson & Johnson Company Detail

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Product

Table 54. Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Novartis Company Detail

Table 57. Novartis Business Overview

Table 58. Novartis Attention Deficit and Hyperactivity Disorder Product

Table 59. Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Eli Lilly Company Detail

Table 62. Eli Lilly Business Overview

Table 63. Eli Lilly Attention Deficit and Hyperactivity Disorder Product

Table 64. Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 65. Eli Lilly Recent Development

Table 66. Tris Pharma Company Detail

Table 67. Tris Pharma Business Overview

Table 68. Tris Pharma Attention Deficit and Hyperactivity Disorder Product

Table 69. Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 70. Tris Pharma Recent Development

Table 71. Neos Therapeutics Company Detail

Table 72. Neos Therapeutics Business Overview

Table 73. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Product

Table 74. Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 75. Neos Therapeutics Recent Development

Table 76. Mallinckrodt Company Detail

Table 77. Mallinckrodt Business Overview

Table 78. Mallinckrodt Attention Deficit and Hyperactivity Disorder Product

Table 79. Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 80. Mallinckrodt Recent Development

Table 81. Amneal Pharmaceuticals Company Detail

Table 82. Amneal Pharmaceuticals Business Overview

Table 83. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product

Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 85. Amneal Pharmaceuticals Recent Development

Table 86. Noven Pharmaceuticals Company Detail

Table 87. Noven Pharmaceuticals Business Overview

Table 88. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product

Table 89. Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 90. Noven Pharmaceuticals Recent Development

Table 91. Purdue Parma Company Detail

Table 92. Purdue Parma Business Overview

Table 93. Purdue Parma Attention Deficit and Hyperactivity Disorder Product

Table 94. Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2019-2024) & (US$ Million)

Table 95. Purdue Parma Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Attention Deficit and Hyperactivity Disorder Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Attention Deficit and Hyperactivity Disorder Market Share by Type: 2023 VS 2030

Figure 3. Stimulant Features

Figure 4. Non-stimulant Features

Figure 5. Global Attention Deficit and Hyperactivity Disorder Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Attention Deficit and Hyperactivity Disorder Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Retail Pharmacy Case Studies

Figure 9. Others Case Studies

Figure 10. Attention Deficit and Hyperactivity Disorder Report Years Considered

Figure 11. Global Attention Deficit and Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Attention Deficit and Hyperactivity Disorder Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Attention Deficit and Hyperactivity Disorder Market Share by Region: 2023 VS 2030

Figure 14. Global Attention Deficit and Hyperactivity Disorder Market Share by Players in 2023

Figure 15. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue in 2023

Figure 17. North America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Attention Deficit and Hyperactivity Disorder Market Share by Country (2019-2030)

Figure 19. United States Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Attention Deficit and Hyperactivity Disorder Market Share by Country (2019-2030)

Figure 23. Germany Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Share by Region (2019-2030)

Figure 31. China Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Attention Deficit and Hyperactivity Disorder Market Share by Country (2019-2030)

Figure 39. Mexico Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Share by Country (2019-2030)

Figure 43. Turkey Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Takeda Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 46. Johnson & Johnson Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 47. Novartis Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 48. Eli Lilly Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 49. Tris Pharma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 50. Neos Therapeutics Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 51. Mallinckrodt Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 53. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 54. Purdue Parma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed